ACADIA Pharmaceuticals Inc.

NASDAQ:ACAD

Biotechnology

Healthcare
$17.59 -0.60%

-$0.13 today

Market cap
$3.04B
Beta
0.83
P/E (TTM)
9.7
EPS (TTM)
$2.20
52W Low $19.69High $28.35

Volume 1.45M

Average 1.66M

Price history

ACADIA Pharmaceuticals Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-23.19%

Period high

$30.57

Period low

$16.50

Latest

$17.59

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
10-QNov 5, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
4Oct 30, 2026Oct 30, 2026
8-KOct 23, 2026Oct 23, 2026
8-KSep 24, 2026Sep 24, 2026
8-KSep 11, 2026Sep 11, 2026
SC 13GAug 7, 2026Aug 7, 2026
4Aug 7, 2026Aug 7, 2026
144Aug 5, 2026Aug 5, 2026
10-QAug 5, 2026Aug 4, 2026
8-KAug 4, 2026Aug 4, 2026
4Jul 31, 2026Jul 31, 2026
4Jun 29, 2026Jun 29, 2026
144Jun 26, 2026Jun 26, 2026

Competitors

Who does ACADIA Pharmaceuticals Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ACAD's filings, answered from its disclosures.

What is the latest ACAD filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does ACAD have?

Intrinsic Alpha currently shows 20 recent filings for ACAD.